ZNF813
Zinc finger protein 813
Also known as: FLJ16542, ZN813_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZN06
- Gene
- ZNF813
- Ensembl
- ENSG00000198346
- Chromosome
- 19
- Canonical length
- 617 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Vesicles
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
617 residues, UniProt reviewed canonical sequence.
>Q6ZN06|ZNF813
1 MALPQGLLTF RDVAIEFSQE EWKCLDPAQR TLYRDVMLEN YRNLVSLDIS SKCMMKEFSS
61 TAQGNREVIH TGTLQRHESH HTGDFRFQEI DKDIHNLEFQ WQEDERNSHE APMTEIKKLT
121 GSADRYDQRH AGNKPIKDQL GSSFHSHLPE LHMFQTQGKI GNQVEKSIND ASSISTSQRI
181 SCRPKTHISN NYGNNFRNSS LLTQKQEVHM REKSFQCNES GKAFNYSSLL RKHQIIHLGE
241 KQYKCDVCGK VFNRKRNLVC HRRCHTGEKP YRCNECGKTF SQTYSLTCHR RLHTGEKPYK
301 CEECDKAFSF KSNLKRHRRI HAGEKPYKCN ECGKTFSQTS SLTCHRRLHT GEKPFKCNEC
361 GKTFSRKSSL TCHHRLHTGE KPYKCNECGK TFSQELTLKC HRRLHTGEKP YKCNECGKVF
421 NKKANLARHH RLHSGEKPYK CTECVKTFSR NSALVIHKAI HIGEKRYKCN ECGKTFSRIS
481 ALVIHTAIHT GEKPYKCNEC GKGFNRKTHL ACHHRLHTGE KPYKCNECGK VFNRKTHLAH
541 HHRLHTGDKP YKCNECGKVF NQKAHLARHH RLHTGEKPYK CNECGKVFNQ KANLARHHRL
601 HTGEKPYKFN ECGKAFNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF813 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 4.6 nTPM
Expression across tissuesHPA
Tissue
- prostate: 4.6 nTPM
- placenta: 3.4 nTPM
- parathyroid gland: 2.2 nTPM
- breast: 2.1 nTPM
- lymph node: 2 nTPM
- thymus: 2 nTPM
Single-cell type
- prostatic glandular cells: 34 nCPM
- extravillous trophoblasts: 32 nCPM
- syncytiotrophoblasts: 30 nCPM
- migrating cytotrophoblasts: 21 nCPM
- cytotrophoblasts: 19 nCPM
- pancreatic islet cells: 18 nCPM
Immune cell
- NK-cell: 3.6 nTPM
- non-classical monocyte: 3.1 nTPM
- naive CD4 T-cell: 3 nTPM
- naive B-cell: 2.4 nTPM
- naive CD8 T-cell: 2.3 nTPM
- memory CD8 T-cell: 1.9 nTPM
Brain region
- white matter: 4.4 nTPM
- medulla oblongata: 4 nTPM
- midbrain: 4 nTPM
- choroid plexus: 3.8 nTPM
- pons: 3.8 nTPM
- basal ganglia: 3.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0.64
- gnomAD missense Z
- -0.65
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF813 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF813 as an antibody target. Whether an autoantibody or antibody against ZNF813 could matter depends on whether native ZNF813 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF813 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF813 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...